Back

CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression

14 May 2024 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Basic science Stem Cells, Cell Cycle, Cell Senescence, Cell Death HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Itamar Dias

University Medical Centre Groningen, Groningen (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Unravelling the diversity of cholinesterases in the murine heart as an essential prerequisite for the use of cholinesterase inhibitors in the treatment of heart failure
Associate Professor A. Hrabovska (Bratislava, SK)
Abstract Slides Video
Presentation thumbnail
Cellular phenotyping of structural and functional changes in atrial myopathy
Doctor J. Huettemeister (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Non-dilated left ventricular cardiomyopathy with arrhythmias is caused by the nonsense founder variant DSP:c.3793G>T in Slovenian patients
Ms N. Vodnjov (Ljubljana, SI)
Abstract Slides Video
Presentation thumbnail
Effect of empagliflozin with or without sacubitril/valsartan on the lipoprotein, glycoprotein and lipid profile in a porcine model of myocardial infarction
Miss D. Martinez-Falguera (Badalona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Basic science

The Event

Event poster

Heart Failure 2024

14 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
CDK4/6 inhibitor ribociclib induces cardiotoxicity through impaired E2F1-regulated spliceosome assembly
thumbnail
Congress Presentation
Future directions
thumbnail
Congress Presentation
Connecting cardiac energetics to transcription factor control of heart failure and regeneration

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources